2022
SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinoma
Hua-Yi Feng, Tao Wang, Jiali Ye, Yang Yang, Xing Huang, Dong-Min Lai, Z. Lv, Yan Huang, Xu Zhang
Discover Oncology
2022
Discover Oncology
2022
Frontiers in Oncology
2022
International Journal of Oncology
2022
Pharmacological Research
2022
Frontiers in Genetics
2022
Human Pathology
2022
Journal of Viral Hepatitis
2021
Frontiers in Oncology
2021
Frontiers in Oncology
2020
Oncology and Translational Medicine
2020
European Respiratory Journal
2017
Tumor Biology
2017
PubMed
2015
Seminars in Cancer Biology
2014
Oncoimmunology
2014
Clinical Biochemistry
此主页由公开资料整理,尚未经学者本人认领。